Famotidine
Is It Right for You?
A complete guide to Famotidine — what it treats, how it works, dosages, side effects, and when a clinician may prescribe it following an online consultation.
What Is Famotidine?
Famotidine is a histamine H2 receptor antagonist (H2 blocker) used to reduce gastric acid secretion and treat a range of acid-related upper gastrointestinal conditions. It is the most potent of the H2 blockers — approximately 7.5 times more potent than ranitidine (now withdrawn) and 20 times more potent than cimetidine — and provides effective, reliable acid suppression suitable for a range of clinical indications from dyspepsia to peptic ulcer disease.
While proton pump inhibitors (PPIs) such as pantoprazole are now considered more effective for sustained acid suppression, famotidine remains a valuable alternative — particularly for patients who do not respond well to or cannot tolerate PPIs, for on-demand relief of heartburn symptoms, and for use in pregnancy (where famotidine has a more established safety record than PPIs).
Famotidine is available as 20 mg and 40 mg tablets. It is rapidly acting (onset within 1 hour) and has a duration of action of approximately 10 to 12 hours, making it suitable for twice-daily dosing or evening dosing for nocturnal acid suppression.
Prescription famotidine (40 mg and certain indications) requires clinical assessment — which can now be done quickly and conveniently through a telehealth consultation.
What Conditions Is Famotidine Used For?
Famotidine is prescribed for:
relief of heartburn, acid regurgitation, and oesophagitis; particularly useful for nocturnal acid breakthrough in patients on PPIs.
treatment of gastric and duodenal ulcers.
management of hypersecretory states.
symptomatic relief of acid-related upper abdominal discomfort, bloating, and nausea.
prevention of peptic ulcers in patients on NSAIDs who cannot tolerate PPIs.
added at bedtime in patients on PPI therapy who experience nocturnal acid breakthrough — an established clinical strategy.
famotidine has a good safety record in pregnancy and is used for pregnancy-related dyspepsia and hyperemesis gravidarum.
- Do not use Famotidine if you have difficulty swallowing, unexplained weight loss, persistent vomiting, or signs of gastrointestinal bleeding (e.g., black stools or blood in vomit).
- Seek urgent medical attention if you experience severe chest pain, especially if it radiates to the arm, neck, or jaw (may indicate heart-related conditions).
- Avoid prolonged self-treatment if symptoms persist beyond 2 weeks or occur frequently, as this may require further evaluation (e.g., for GERD or ulcers).
- Use with caution in patients with kidney impairment, as dose adjustment may be required.
- If symptoms worsen or new symptoms develop while taking Famotidine, discontinue use and consult a healthcare professional.
How Does Famotidine Work?
Famotidine competitively and reversibly blocks histamine H2 receptors on the basolateral membrane of gastric parietal cells. Histamine — released by enterochromaffin-like (ECL) cells of the gastric mucosa in response to gastrin and vagal stimulation — is the primary stimulant of acid secretion, acting via H2 receptors to activate adenylyl cyclase and increase intracellular cAMP, ultimately activating the proton pump (H⁺/K⁺-ATPase).
By blocking H2 receptors, famotidine reduces both basal (fasting) and meal-stimulated gastric acid secretion, as well as nocturnal acid production. Unlike PPIs, which irreversibly inhibit the proton pump, famotidine's H2 blockade is competitive and reversible — its effects are somewhat shorter-lived (approximately 10 to 12 hours), meaning twice-daily dosing is often needed for sustained 24-hour acid suppression.
Tolerance (tachyphylaxis) can develop with regular H2 blocker use — sustained acid suppression is somewhat diminished after continuous daily use for 1 to 2 weeks, which limits their utility for long-term maintenance compared to PPIs. However, famotidine retains its effectiveness for on-demand or nocturnal use.
Dosages & Administration
The correct dose depends on the type and severity of infection, age, weight, and kidney function. Always follow your clinician's instructions. The table below is for general reference only.
Administration Tips
For nocturnal symptoms or ulcer healing, taking the full daily dose at night is often preferred — acid secretion is highest at night, and a single bedtime dose targets this peak effectively.
For twice-daily dosing, take one dose in the morning and one at bedtime.
Famotidine works relatively quickly (within 1 hour) compared to PPIs, making it suitable for on-demand use before a meal known to trigger symptoms.
Avoid taking antacids within 1 hour of famotidine, as antacids may impair its absorption.
Dose reduction is required in renal impairment — famotidine is renally excreted. In patients with eGFR < 50 mL/min, the dose or frequency should be halved. Discuss with your clinician.
Side Effects of Famotidine
Famotidine is one of the best-tolerated H2 blockers, with a very low rate of side effects compared to older agents such as cimetidine.
- Headache
- Dizziness
- Diarrhoea or constipation
- Nausea
- Fatigue
- Cardiac arrhythmias — QT interval prolongation reported at high doses; rare
- CNS effects — confusion, agitation, hallucinations; rare; risk increased in elderly or renally impaired patients
- Thrombocytopenia — rare reduction in platelet count
- Hepatic dysfunction — rare elevation in liver enzymes
- Severe hypersensitivity — rare anaphylaxis, angioedema
Famotidine is primarily renally excreted. In patients with significant renal impairment, drug accumulation can cause CNS side effects including confusion and hallucinations. Dose reduction or extended dosing intervals are required. Inform your clinician of any renal impairment before starting famotidine.
Drug Interactions
Famotidine has a significantly cleaner drug interaction profile than cimetidine, which is a potent CYP450 inhibitor. The following interactions apply:
Reduced gastric acidity impairs the absorption of pH-dependent drugs.
May reduce famotidine absorption if taken simultaneously; space doses by at least 2 hours.
Reduces renal excretion of famotidine; modest increase in famotidine levels.
May modestly reduce famotidine absorption; separate by at least 1 hour.
Important Warnings
Unlike PPIs, H2 blockers including famotidine develop tolerance (tachyphylaxis) with continuous daily use — typically after 1 to 2 weeks of regular dosing. For long-term acid suppression, PPIs are generally more effective. Famotidine is best used on an as-needed basis, for short courses, or as an add-on to PPI therapy for nocturnal symptoms.
As with all acid-suppressing medications, long-term use without investigation risks masking symptoms of gastric cancer. Alarm symptoms (unexplained weight loss, dysphagia, anaemia, vomiting) require endoscopic investigation before or despite acid suppression.
Famotidine is considered one of the safer options for managing acid reflux during pregnancy and has been used extensively in this context. It crosses the placenta and is detectable in breast milk in small amounts. Discuss with your clinician before use in pregnancy or breastfeeding.
Speak to a Clinician About Treatment
Getting advice no longer means sitting in a waiting room. Through The GP Service, you can consult with a licensed clinician in minutes — from home, on your lunch break, or wherever works for you. If treatment is clinically appropriate, your clinician can issue a prescription during the consultation. A consultation does not guarantee a prescription.
The treatment you need, when you need it.
Famotidine FAQs
For mild to moderate GORD and heartburn, famotidine can be very effective. For more severe oesophagitis or for long-term maintenance, PPIs generally provide superior and more sustained acid suppression because they irreversibly inhibit proton pumps rather than competitively blocking histamine receptors. Famotidine is particularly useful for on-demand heartburn relief, nocturnal acid breakthrough as an add-on to PPIs, and in patients who prefer or require an alternative to PPIs.
Yes — this is a recognised clinical strategy for patients on PPIs who experience "nocturnal acid breakthrough" (acid secretion resuming in the early hours, causing night-time symptoms). Adding a bedtime dose of an H2 blocker such as famotidine to a daily PPI can effectively suppress nocturnal acid. However, tolerance to the H2 blocker tends to develop with nightly use, so this strategy is typically most effective when used intermittently rather than every night.
Famotidine is considered one of the more extensively studied and safer H2 blockers for use in pregnancy. Available evidence does not suggest a meaningful increase in fetal risk. It is often preferred over PPIs in pregnancy due to a longer safety record in this context. Always consult your clinician before taking any medication during pregnancy.
Ranitidine was voluntarily and then mandatorily withdrawn from the market globally from 2019 to 2020, following the discovery that it could degrade over time into a potential carcinogen called NDMA (N-nitrosodimethylamine). Famotidine does not have this degradation issue and is the most commonly prescribed H2 blocker now that ranitidine is no longer available.